Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Search

Page Path
HOME > Search
1 "Clostridium difficile"
Filter
Filter
Article category
Keywords
Publication year
Authors
Review
IBD
Management of Clostridioides difficile infection in patients with inflammatory bowel disease
Sahil Khanna
Intest Res 2021;19(3):265-274.   Published online August 18, 2020
DOI: https://doi.org/10.5217/ir.2020.00045
AbstractAbstract PDFPubReaderePub
Inflammatory bowel disease (IBD) is a common diarrheal illness with gastrointestinal and extraintestinal manifestations and complications. The most common infectious complication associated with IBD is Clostridioides difficile infection (CDI). Active IBD predisposes to CDI due to alterations in the gut microbiome. C. difficile is a toxin producing bacterium leading to worsening of underlying IBD, increasing the risk of IBD treatment failure and an increased risk of hospitalization and surgery. Since the symptoms of CDI overlap with those of an IBD flare; it is prudent to recognize that the diagnosis of CDI is challenging and diagnostic tests (nucleic-acid and toxin-based assays) should be interpreted in context of symptoms and test performance. First line treatments for management of CDI in IBD include vancomycin or fidaxomicin. Recurrence prevention strategies should be implemented to mitigate recurrent CDI risk. One needs to monitor IBD disease progression and manage immunosuppression. The risk of recurrent CDI after a primary infection is higher in IBD compared to non-IBD patients. Microbiota restoration therapies are effective to prevent recurrent CDI in IBD patients. This review summarizes the epidemiology, pathophysiology, diagnostic testing, outcomes and management of both CDI and IBD, in CDI complicating IBD.

Citations

Citations to this article as recorded by  
  • Higher disease activity of inflammatory bowel disease predisposes to Clostridioides difficile infection
    Krista Vitikainen, Merit Kase, Leo Meriranta, Pauliina Molander, Clas-Göran af Björkesten, Veli-Jukka Anttila, Perttu Arkkila
    Therapeutic Advances in Gastroenterology.2025;[Epub]     CrossRef
  • Discordance in Clinical Indicators With Sequential Fecal Microbiota Transplantation: A Case of Fulminant Clostridioides Difficile Infection
    Peter Bhandari, Reanay Berezovskiy, Salima Makhani, Valerie Gausman, Neelesh Rastogi, Sabina Braude
    ACG Case Reports Journal.2025; 12(6): e01731.     CrossRef
  • Phage therapy modulates the gut microbiome and immune responses in non-typhoidal Salmonella-induced colitis
    Md. Sharifull Islam, Ping Wei, Kaimin Zhang, Ishatur Nime, Fan Pan
    Food Research International.2025; 219: 117003.     CrossRef
  • Recurrent Clostridium difficile Infections in a Patient With Ulcerative Colitis: A Case Report
    Osama Nadeem, Muhammad Soban Imran, Nasir Siddique
    Cureus.2025;[Epub]     CrossRef
  • Patient with Inflammatory Bowel Disease in a Dental Office—Which Antibiotic to Choose?—Narrative Review
    Stanisław Niemczyk, Wojciech Niemczyk, Katarzyna Bąk-Drabik, Katarzyna Latusek-Kotyczka, Anna Zawilska, Rafał Wiench, Jakub Hadzik, Marzena Dominiak
    Journal of Clinical Medicine.2025; 14(23): 8392.     CrossRef
  • Enteric opportunistic infections in patients with inflammatory bowel disease receiving biologic therapies: a retrospective cohort study
    Ting-Chieh Huang, Tony Kou, Chia-Jung Kuo, Cheng-Hsun Chiu, Tai-Di Chen, Chien-Ming Chen, Jen-Wei Chou, Tien-Yu Huang, Chen-Wang Chang, Cheng-Tang Chiu, Ming-Yao Su, Yu-Bin Pan, Puo-Hsien Le
    Gut Pathogens.2025;[Epub]     CrossRef
  • Special Issue “Bacterial Toxins and Cancer”
    Sara Travaglione, Francesca Carlini, Zaira Maroccia, Alessia Fabbri
    International Journal of Molecular Sciences.2024; 25(4): 2128.     CrossRef
  • 19-Year-Old Man With Abdominal Pain, Vomiting, Bloody Diarrhea, and Rash
    David L. Farrier, David Chiang, Amindra S. Arora
    Mayo Clinic Proceedings.2024; 99(6): 980.     CrossRef
  • Pharmacological effects of ginseng and ginsenosides on intestinal inflammation and the immune system
    Linxian Zhao, Tongbo Zhang, Kai Zhang
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • Clostridioides difficile infection in inflammatory bowel disease: a clinical review
    Mengjun Tang, Chunhua Wang, Ying Xia, Jian Tang, Jiao Wang, Liang Shen
    Expert Review of Anti-infective Therapy.2024; 22(5): 297.     CrossRef
  • Management of Clostridioides difficile infection: an Italian Delphi consensus
    Matteo Bassetti, Antonio Cascio, Francesco Giuseppe De Rosa, Marianna Meschiari, Roberto Parrella, Nicola Petrosillo, Alessandro Armuzzi, Flavio Caprioli, Francesco Dentali, Marcello Pani, Alberto Pilotto, Umberto Restelli, Maurizio Sanguinetti
    Journal of Antimicrobial Chemotherapy.2024; 79(9): 2103.     CrossRef
  • Treatment outcomes of mild to moderate Clostridioides difficile infection in inflammatory bowel disease: an Australian experience
    Rachael Jacob, Virginia Chu, Watson Ng, Astrid‐Jane Williams, Susan Connor
    Internal Medicine Journal.2024; 54(12): 2009.     CrossRef
  • Clinical outcomes for Clostridioides difficile associated diarrhea in inflammatory bowel disease patients versus non-IBD population: A retrospective cohort study
    Genady Drozdinsky, Alaa Atamna, Hagar Banai, Haim Ben-Zvi, Jihad Bishara, Noa Eliakim-Raz
    Medicine.2023; 102(6): e32812.     CrossRef
  • Clostridioides difficile Toxin B Induced Senescence: A New Pathologic Player for Colorectal Cancer?
    Katia Fettucciari, Alessandro Fruganti, Fabrizio Stracci, Andrea Spaterna, Pierfrancesco Marconi, Gabrio Bassotti
    International Journal of Molecular Sciences.2023; 24(9): 8155.     CrossRef
  • Low prevalence of Clostridioides difficile infection in acute severe ulcerative colitis: A retrospective cohort study from northern India
    Sandeep Mundhra, David Thomas, Saransh Jain, Pabitra Sahu, Sudheer Vuyyuru, Peeyush Kumar, Bhaskar Kante, Rajesh Panwar, Peush Sahni, Rama Chaudhry, Prasenjit Das, Govind Makharia, Saurabh Kedia, Vineet Ahuja
    Indian Journal of Gastroenterology.2023; 42(3): 411.     CrossRef
  • Risk of all-cause and cause-specific mortality associated with immune-mediated inflammatory diseases in Korea
    Oh Chan Kwon, See Young Lee, Jaeyoung Chun, Kyungdo Han, Yuna Kim, Ryul Kim, Min-Chan Park, Jie-Hyun Kim, Young Hoon Youn, Hyojin Park
    Frontiers in Medicine.2023;[Epub]     CrossRef
  • Fidaxomicin treatment for Clostridioides difficile infection in patients with inflammatory bowel disease
    Andree H Koop, Paul M Travers, Sahil Khanna, Darrell S Pardi, Francis A Farraye, Jana G Hashash
    Journal of Gastroenterology and Hepatology.2023; 38(11): 1910.     CrossRef
  • Clostridioides difficile Infection in Inflammatory Bowel Disease Patients: A Systematic Review of Risk Factors and Approach in Management
    Leslie Sangurima, Maujid Masood Malik, Nency Ganatra, Rosemary Siby, Sanjay Kumar, Sara Khan, Doju Cheriachan, Lubna Mohammed
    Cureus.2023;[Epub]     CrossRef
  • Role of the Alteration in Calcium Homeostasis in Cell Death Induced by Clostridioides difficile Toxin A and Toxin B
    Katia Fettucciari, Fabrizio Dini, Pierfrancesco Marconi, Gabrio Bassotti
    Biology.2023; 12(8): 1117.     CrossRef
  • Gut Microbiota Associated with Clostridioides difficile Carriage in Three Clinical Groups (Inflammatory Bowel Disease, C. difficile Infection and Healthcare Workers) in Hospital Field
    Elisa Martinez, Sebastien Crevecoeur, Carine Thirion, Jessica Grandjean, Papa Abdoulaye Fall, Marie-Pierre Hayette, Moutschen Michel, Bernard Taminiau, Edouard Louis, Georges Daube
    Microorganisms.2023; 11(10): 2527.     CrossRef
  • Prevalence of Clostridium Difficile Infection (CDI) among Inflammatory Bowel Disease (IBD) Patients in Comparison to Non-IBD Patients in King Abdulaziz Medical City in Jeddah
    Ghassan Abdulrahman Sukkar, Syed Sameer Aga, Abdulrahman Hamid Alsamadani, Faisal Ghazi Almalki, Ali Saleh Alsudais, Abdulrahman Sulaiman Alquzi, Mohamed Eldigire Ahmed, Mushtaq Ahmad Mir, Moudi M. Alasmari, Shivendra Singh
    Interdisciplinary Perspectives on Infectious Diseases.2023; 2023: 1.     CrossRef
  • Comparison of 1-Year Colectomy Risk Between the US and Korean Patients with Acute Severe Ulcerative Colitis: A Propensity Score Matching Analysis
    Eun Soo Kim, Kyeong Ok Kim, Byung Ik Jang, Eun Young Kim, Yoo Jin Lee, Hyun Seok Lee, Joon Seop Lee, Sung Kook Kim, Yun Jin Jung, Sang-Bum Kang, Manasi Agrawal, Ryan Ungaro, Jean-Frederic Colombel
    Digestive Diseases and Sciences.2022; 67(7): 2866.     CrossRef
  • Risk factors for Clostridioides difficile infection in children and adolescents with inflammatory bowel disease: a systematic review and meta-analysis
    Sheng-Bo Fang, Yan-Qing Song, Chun-Yan Zhang, Li-Bo Wang
    World Journal of Pediatrics.2022; 18(1): 27.     CrossRef
  • Clostridium innocuum infection in hospitalised patients with inflammatory bowel disease
    Puo-Hsien Le, Cheng-Tang Chiu, Pai-Jui Yeh, Yu-Bin Pan, Cheng-Hsun Chiu
    Journal of Infection.2022; 84(3): 337.     CrossRef
  • Immunology of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutics
    Quan Lu, Mei-feng Yang, Yu-jie Liang, Jing Xu, Hao-ming Xu, Yu-qiang Nie, Li-sheng Wang, Jun Yao, De-feng Li
    Journal of Inflammation Research.2022; Volume 15: 1825.     CrossRef
  • Clostridioides Infection in Patients with Inflammatory Bowel Disease
    Mi Rae Lee, Eun Soo Kim
    The Korean Journal of Gastroenterology.2022; 80(2): 66.     CrossRef
  • Viral Hepatitis in Patients with Inflammatory Bowel Disease
    Seung Hwan Shin, Sang Hyoung Park
    The Korean Journal of Gastroenterology.2022; 80(2): 51.     CrossRef
  • Exploration of Potential Gut Microbiota-Derived Biomarkers to Predict the Success of Fecal Microbiota Transplantation in Ulcerative Colitis: A Prospective Cohort in Korea
    Gi-Ung Kang, Sowon Park, Yeongyun Jung, Jai J. Jee, Min-Sueng Kim, Seungjun Lee, Dong-Woo Lee, Jae-Ho Shin, Hong Koh
    Gut and Liver.2022; 16(5): 775.     CrossRef
  • Do We Have an Opportunity to Avoid Opportunistic Infections in Asian Patients with Inflammatory Bowel Disease?
    Suhyun Park, Sang Hyoung Park
    Gut and Liver.2022; 16(5): 663.     CrossRef
  • Microbial Modulation in Inflammatory Bowel Diseases
    Jongwook Yu, Jae Hee Cheon
    Immune Network.2022;[Epub]     CrossRef
  • Using next-generation sequencing to develop a Shigella species threshold and profile faecal samples from suspected diarrhoea cases
    Ann Smith
    Folia Microbiologica.2021; 66(3): 399.     CrossRef
  • Decreased secondary faecal bile acids in children with ulcerative colitis and Clostridioides difficile infection
    Sarah Rotondo‐Trivette, Beibei Wang, Christopher Gayer, Riddhi Parsana, Yihui Luan, Fengzhu Sun, Sonia Michail
    Alimentary Pharmacology & Therapeutics.2021; 54(6): 792.     CrossRef
  • Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease May be Favoured by the Effects of Proinflammatory Cytokines on the Enteroglial Network
    Gabrio Bassotti, Alessandro Fruganti, Giovanni Maconi, Pierfrancesco Marconi, Katia Fettucciari
    Journal of Inflammation Research.2021; Volume 14: 7443.     CrossRef
  • 23,262 View
  • 657 Download
  • 31 Web of Science
  • 33 Crossref
Close layer

Intest Res : Intestinal Research
Close layer
TOP